Funding of just under £50k from IBioIC enabled Ingenza to gain invaluable expertise and enhanced their ability to access new markets and end users thanks to the technology developed as a result of this project.
Read MoreA new predictive model for more efficient production of proteins as pharmaceuticals, industrial biocatalysts or numerous other engineering biology applications.
Read MoreIn this project, IBioIC funded a team of scientists at Edinburgh University to work with ILC Therapeutics to develop a platform that could produce hybrid proteins, based on the Type 1 Interferons, with enhanced cancer fighting capabilities.
Read MoreGlycoproteins made using yeast have the potential to significantly reduce the cost of treatments for the NHS.
Read MoreIBioIC funded a collaboration between 3F BIO and the University of Strathclyde to develop and test a sustainable protein production process which advanced the company's progress towards commercialisation.
Read More3F BIO delivered their 18-month Proof of Concept programme whilst commissioning their equipment and operating systems within RapidBio, our facility in Glasgow.
Read More